Position in OGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$22,248,750
+$8,910,736 QoQ
Shares Held
1,643,187
-26.2% QoQ
Ownership
0.626%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 626 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 0%
Shared 95%
None 5%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $27,851,957,097 across 16 Drug Manufacturers - General names. OGN ranks #14 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
16,320,446 | $5,909,959,895 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
39,819,151 | $5,030,751,525 | |
| 3 | LLY |
ELI LILLY & Co
|
3,694,152 | $4,430,877,092 | |
| 4 | JNJ |
Johnson & Johnson
|
15,674,093 | $3,980,749,389 | |
| 5 | MRK |
Merck & Co., Inc.
|
18,611,171 | $2,391,535,466 | |
| 6 | AZN |
Astrazeneca PLC
|
10,177,013 | $1,929,765,193 | |
| 7 | ABBV |
AbbVie Inc.
|
7,114,782 | $1,790,363,732 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
16,033,480 | $923,849,108 |
All Filings in OGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,248,750 | 1,643,187 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $13,338,014 | 2,226,714 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $15,933,515 | 2,222,248 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $17,183,005 | 1,608,896 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $15,589,200 | 1,610,455 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $28,848,061 | 1,937,412 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $30,358,914 | 2,034,780 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $26,912,769 | 1,406,836 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $44,873,519 | 2,167,803 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $43,901,400 | 2,335,181 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $24,458,538 | 1,696,154 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $177,777,331 | 10,240,630 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $172,243,281 | 8,276,948 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $164,984,893 | 7,014,664 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $124,779,309 | 4,467,573 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $92,680,493 | 3,960,705 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $131,243,587 | 3,888,699 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $122,754,460 | 3,514,299 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $122,389,173 | 4,019,349 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $105,314,524 | 3,211,788 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $107,090,499 | 3,539,012 | Shares | Sole | 2021-08-17 | |
| No filing history on record for this holder in this stock. | ||||||